Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "VILYUYSKAYA APTEKA N5" MUNITSIPAL'NOGO RAYONA "VILYUYSKIY ULUS (RAYON)" RESPUBLIKI SAKHA (YAKUTIYA) |
|---|
INN | 1410001240 |
|---|
KPP | 141001001 |
|---|
OGRN | 1021400641239 |
|---|
OKPO | 36950390 |
|---|
Address | 678200, Respublika Sakha (yakutiya), u. Vilyuyskiy, g. Vilyuysk, ul. Mira, d. D. 42 |
|---|
Phone | +7 (411) 324-29-32 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 21.20.1 | Additional activity | Production of drugs | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | All types of activities | | 47.75.2 | Additional activity | Retail drugstore products |
Registration date | 03.10.2002 |
|---|
Registering department | Komitet po upravleniyu kommunal'nym imuschestvom Vilyuyskogo ulusa Respubliki Sakha (Yakutiya) |
|---|
|
MUP "APTEKA N5" (Sakha (Yakutia) Republic; INN 1410001240) was registered on 3 Oct 2002. The company's authorized capital as of July 1, 2012 was 15366233 rub. Type of ownership of MUP "APTEKA N5" - Unitary enterprises based on the principle of economic management. Form of ownership of MUP "APTEKA N5" - Municipal property. Principal activities of MUP "APTEKA N5": retailing drugs in specialized stores (pharmacies) (47.73), production of drugs (21.20.1), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of MUP APTEKA N5 dropped in 2023 by 10.46% to 334.00 thousand RUB from 373.00 thousand RUB over the same period in 2022, the company informed. Revenue remained in the accounting period at the same level and made up 67.99 million RUB compared to 68.03 million RUB 68.03 million RUB; cost of goods sold grew by 2.34% to 47.83 million RUB from 46.73 million RUB; sales profit fell by 32.13% to 1.07 million RUB from 1.58 million RUB. 2022
Net profit (RAS) of MUP APTEKA N5 grew over 2022 by 17.67% to 373.00 thousand RUB from 317.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 33.28% to 68.03 million RUB from 51.05 million RUB over 2021; cost of goods sold grew by 37.83% to 46.73 million RUB from 33.91 million RUB; sales profit went up 2.17 times to 1.58 million RUB from 727.00 thousand RUB. 2021
Net profit (RAS) of MUP APTEKA N5 grew over 2021 1.54 times to 317.00 thousand RUB from 206.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 1.28% to 51.05 million RUB from 50.40 million RUB over 2020; cost of goods sold remained at the same level amounting to 33.91 million RUB compared to 33.89 million RUB; sales profit fell by 41.65% to 727.00 thousand RUB from 1.25 million RUB. 2020
Net profit (RAS) of MUP APTEKA N5 grew over 2020 1.87 times to 206.00 thousand RUB from 110.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 3.65% to 50.40 million RUB from 48.63 million RUB over 2019; cost of goods sold grew by 12.44% to 33.89 million RUB from 30.14 million RUB; sales profit went up 2.35 times to 1.25 million RUB from 530.00 thousand RUB. 2018
Net profit (RAS) of MUP APTEKA N5 made up 1.32 million RUB over 2018 compared to net loss of 1.32 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 1.33% to 53.37 million RUB from 54.09 million RUB in 2017; cost of goods sold remained at the same level amounting to 33.74 million RUB compared to 33.77 million RUB; sales profit went up 3.11 times to 1.82 million RUB from 585.00 thousand RUB. 2017
Net loss (RAS) of MUP APTEKA N5 increased 1.92 times to 1.32 million RUB from 688.00 thousand RUB over 2016, the company informed. Revenue decreased in the accounting period by 23.44% to 54.09 million RUB from 70.65 million RUB in 2016; cost of goods sold decreased by 26.17% to 33.77 million RUB from 45.74 million RUB; sales profit fell by 26.60% to 585.00 thousand RUB from 797.00 thousand RUB. 2016
Net loss (RA) of MUP APTEKA N5 made up 688.00 thousand RUB over 2016 compared to net profit of 549.00 thousand RUB over 2015, the company informed. Revenue remained in the accounting period at the same level and made up 70.65 million RUB compared to 70.71 million RUB 70.71 million RUB; cost of goods sold decreased by 2.63% to 45.74 million RUB from 46.97 million RUB; sales profit fell by 49.17% to 797.00 thousand RUB from 1.57 million RUB. 2014
Net profit (RAS) of MUP Apteka 5 grew over 2014 15.36 times to 599.00 thousand RUB from 39.00 thousand RUB over 2013, the company informed. Revenue remained in the accounting period at the same level and made up 67.65 million RUB compared to 67.64 million RUB 67.64 million RUB; cost of goods sold decreased by 0.89% to 44.17 million RUB from 44.57 million RUB; sales profit went up by 17.50% to 1.52 million RUB from 1.30 million RUB. 2013
Net profit (RAS) of MUP Apteka 5 dropped in 2013 33.03 times to 39.00 thousand RUB from 1.29 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 30.54% to 67.64 million RUB from 51.81 million RUB over 2012; cost of goods sold grew by 36.42% to 44.57 million RUB from 32.67 million RUB; sales profit made up 1.30 million RUB compared to sales loss of 1.19 million RUB. 2012
Net profit (RAS) of MUP Apteka 5 made up 1.29 million RUB over 2012 compared to net loss of 1.07 million RUB over 2011, the company informed. Cost of goods sold grew by 36.79% to 32.67 million RUB from 23.88 million RUB; sales loss grew by 38.02% to 1.19 million RUB from 860.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|